Gist Weekly Newsletter
Gist Weekly: August 21, 2026
In the News
What happened in healthcare recently—and what we think about it.
- Rating agencies release medians reports. U.S. not-for-profit hospitals entered 2026 in much better shape than in 2022-2023, new medians reports from the three major ratings agencies released this summer found. Performance softened after the 2024 recovery, according to Moody’s, but Fitch Ratings noted that 2026 medians mark the third consecutive year of improvement. Meanwhile, S&P Global Ratings found improved balance sheets supported by strong demand and revenue growth, despite softened operating gains, as most outlooks remained stable with negative outlooks declining. Yet, expense growth and modest improvement in operating margin—with significant geographic variability—slowed performance, according to Moody’s and S&P. Looking ahead, Fitch cautioned that tighter Medicaid eligibility and funding rules may weaken payer mix and create more financial pressure in 2027. This could place renewed weight on margins and test the cushion that not-for-profit health organizations have rebuilt since the Covid-19 pandemic.
- The Gist: Published medians serve as barometers, helping to benchmark what “normal” financial performance should look like for healthcare organizations. The overall news is good, as median financial performance margins showed overall stability through FY 2025 but remain below pre-pandemic levels, notes Lisa Goldstein, a managing director in Kaufman Hall’s Treasury and Capital Markets practice. Capital spending increased materially in FY 2025 as hospitals ramped up spending for routine and strategic needs; the average age of plant median held steady. Meanwhile, cash-to-debt median improved, largely due to growth in absolute cash balances given favorable investment market conditions. The medians reports are not individual rating actions nor changes to industry outlooks. Rather, they indicate a resilient healthcare sector in recovery even as new policy risks appear on the horizon.
- Moody’s upgrades two hospital districts to Aaa. Two hospital districts received the first triple-A rating ever achieved in U.S. healthcare. The ratings upgrades were awarded Aug. 7 by Moody’s following a recent methodology change that prompted an upgrade to two California hospital districts, El Camino Hospital District and Grossmont Hospital District, for their unlimited-tax general-obligation debt. Their underlying issuer/revenue ratings remain lower at a still-healthy Aa3. The upgrades were enabled by the methodological change, which Moody’s enacted in May, to allow tax-backed debt to be modified based on additional protections. The change affects roughly 50 hospital district general-obligation ratings, which Moody’s is reviewing this summer.
- The Gist: The two California hospital districts join an elite club, which is uncommon in any field, but with an important distinction. The Aaa ratings apply to debt backed by the districts’ unlimited taxing authority, not hospital revenues. To date, no hospital has achieved a Aaa rating based on revenue-backed debt alone. Still, the ratings are notable: the assignment of Aaa is an industry first, and breaks through an unofficial rating ceiling for hospitals. The distinction speaks to hospitals’ unusual risk profile. In municipal finance, plenty of states, cities, and counties enjoy Aaa tax-backed ratings without the enterprise risk that a hospital carries. Likewise, there are colleges and universities with Aaa ratings that have no taxing ability, yet carry an abundance of wealth and less operating risk. In corporate finance, only three U.S. companies sit at the top of the credit spectrum—Apple, Microsoft, and Johnson & Johnson—in which substantial enterprise risk is offset by exceptional financial strength, global brands, and global demand. So, move over, Apple, Microsoft, and Johnson & Johnson.
And—what we’re following.
- Universal Health Services (UHS) announced Monday it has completed its acquisition of digital health technology platform Talkspace, which will add more than 6,000 behavioral health providers, particularly in rural areas.
- Prescription drug prices fell by 3.1% in the year ending in July, the steepest annual decline in more than 60 years, according to Bureau of Labor Statistics data released Wednesday.
Plus—what we’ve been reading.
- AI-generated viruses. This recent New York Times article describes the development of new kinds of viruses, created by AI. A research team taught AI to recognize DNA patterns and write new virus genomes, with similar biology to natural species. The new viruses can only infect bacteria, and researchers say they do not pose threats to humans and animals. As a precautionary measure, researchers did not introduce data about viruses that infect animals, plants, or fungi. This news comes as the National Institutes of Health released a new policy on stopping high-risk research, yet scientists note that there is no consensus on evaluating the possible dangers of AI-generated viruses.
- The Gist: The AI bioengineering train has left the station. The debate over AI governance now extends into an unexpected frontier: novel biology. While synthesizing new viruses is not new to science, AI-generated viruses represent a new milestone in research and carry unique implications. AI-generated viruses, in particular bacteriophages, can be used to treat bacterial infections and speed up discovery and development of new antibiotics. Yet, scientists have frameworks for managing human-led high-risk research, not for those designed by AI. AI-designed organisms introduce risks that are impossible to anticipate, measure, or contain. They may pose serious biosafety concerns. For hospitals and health systems with research enterprises, this raises a new governance and operations question: are we ready? The opportunity for treatment innovation is significant, but so is the uncertainty.
Graphic of the Week
A key insight illustrated in infographic form.
Hospital performance remains under pressure from growing uncompensated care and expense inflation, according to Kaufman Hall’s latest National Hospital Flash Report. Bad debt and charity care continued to grow year-to-date through June amid ongoing payer mix challenges. At the same time, productivity growth is offsetting medical group cost pressures but stretching providers, according to the Q2 2026 Physician Flash Report.
This Week at Kaufman Hall
What our experts are saying about key issues in healthcare.
Hospital leaders are navigating growing uncertainty around the healthcare safety net, AI, and the need for greater scale and consolidation. Making sound strategic decisions will require asking difficult, evidence-based questions and being willing to challenge long-held assumptions.
In his new blog, Ken Kaufman explores the critical questions leaders should be asking—and how they can begin finding answers.
On Our Podcast
The Gist Healthcare Podcast—all the headlines in healthcare policy, business and more, in 10 minutes or less every other weekday morning.
The podcast is taking a short break for the end of summer, returning after Labor Day with the latest health care news and conversations. Until then, thanks for listening, and we hope you enjoy the rest of your summer.
Thanks for reading! The Gist Weekly will be on hiatus for Labor Day and will return September 11. In the meantime, please check out our Gist Weekly archive for past editions. We also have all our recent Graphics of the Week available here.
Best regards,
The Gist Weekly team at Kaufman Hall